# Novel Induction to Buprenorphine/Naloxone

> **NCT05644587** · PHASE4 · TERMINATED · sponsor: **Bicycle Health** · enrollment: 33 (actual)

## Conditions studied

- Opioid Use Disorder
- Opioid Use
- Opioid Abuse
- Opioid Misuse
- Opioid Dependence

## Interventions

- **DRUG:** buprenorphine/naloxone

## Key facts

- **NCT ID:** NCT05644587
- **Lead sponsor:** Bicycle Health
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-02-06
- **Primary completion:** 2023-11-30
- **Final completion:** 2023-11-30
- **Target enrollment:** 33 (ACTUAL)
- **Why stopped:** Low enrollment numbers
- **Last updated:** 2024-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05644587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05644587, "Novel Induction to Buprenorphine/Naloxone". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05644587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*